Human anti-KIR antibodies
US8981065B2 · kind B2 · utility
13Cited by
9References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 8, 2013 |
| Grant date | Mar 17, 2015 |
| Priority date | — |
| Expiry date | Jul 8, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for regulating an immune response in a subject are described. More particularly, described are human antibodies that regulate the activity of NK cells and allow a potentiation of NK cell cytotoxicity in mammalian subjects, and antibodies having antigen-binding properties similar to those of human monoclonal antibody 1-7F9 or 1-4F1. Described also are also fragments and derivatives of such antibodies, as well as pharmaceutical compositions comprising the same and their uses, particularly for use in therapy, to increase NK cell activity or cytotoxicity in subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.